ArticleTrials2025

Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial.

Bjørn Blomberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.